2nd TCR-based Therapies Summit
Evvnt Promotion / evvnt
Archiv
08.06.2021 - 10.06.2021 Virtual
Time: 09:30 to 16:15
Kongressthemen
Running digitally for 2021, the 2nd TCR-based Therapies Summit is the leading industry-focused meeting dedicated to supercharging the expanded TCR repertoire through enhanced target specificity, density and binding affinity for solid tumor indications.
Running digitally for 2021, the 2nd TCR-based Therapies Summit is the leading industry-focused meeting dedicated to supercharging the expanded TCR repertoire through enhanced target specificity, density and binding affinity for solid tumor indications.
Kongressorganizer (PCO)
Hanson Wade
Hanson Wade
Anmerkungen
Brochure: https://go.evvnt.com/730790-3?pid=4832
Speakers: Hans-Peter Gerber SVP and CSO 3T Biosciences, Joseph Dukes VP Translational Sciences Enara Bio, Leah Sibener Co-founder, Head of Therapeutic Discovery 3T Bioscience, and more.
Brochure: https://go.evvnt.com/730790-3?pid=4832
Speakers: Hans-Peter Gerber SVP and CSO 3T Biosciences, Joseph Dukes VP Translational Sciences Enara Bio, Leah Sibener Co-founder, Head of Therapeutic Discovery 3T Bioscience, and more.
Anfragen und Anmeldung:
https://go.evvnt.com/730790-2?pid=4832
Herr Customer Service
Allgemeinmedizin
Sprache
Englisch
Englisch
Kongressgebühr
Conference Only: USD 2499.00, Conference + 2 Workshops: USD 3297.00, Conference + Focus Day: USD 3297.00
Conference Only: USD 2499.00, Conference + 2 Workshops: USD 3297.00, Conference + Focus Day: USD 3297.00
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
83 Great Titchfield Street
W1W 6RH London
Großbritannien
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."
